CYTORI THERAPEUTICS, INC. Uncategorized Contracts & Agreements
43 Contracts & Agreements
- Cancer Research Grant Contract, effective August 31, 2022, by and between the Cancer Prevention and Research Institute of Texas and Plus Therapeutics, Inc (Filed With SEC on September 22, 2022)
- Description of Securities (Filed With SEC on March 30, 2020)
- Amendment to Dealer-Manager Agreement, dated as of July 24, 2018, by and between Cytori Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on July 25, 2018)
- CERTAIN MATERIAL (INDICATED BY ASTERISKS) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH... (Filed With SEC on August 11, 2017)
- CERTAIN MATERIAL (INDICATED BY ASTERISKS) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH... (Filed With SEC on August 11, 2017)
- PAGE OF PAGES (Filed With SEC on March 24, 2017)
- PAGE OF PAGES (Filed With SEC on March 24, 2017)
- PAGE OF PAGES (Filed With SEC on November 9, 2016)
- PAGE OF PAGES (Filed With SEC on August 5, 2016)
- CYTORI THERAPEUTICS, INC. (Filed With SEC on June 13, 2016)
- FORM OF CYTORI THERAPEUTICS, INC. DEALER-MANAGER AGREEMENT , 2016 (Filed With SEC on May 11, 2016)
- CYTORI THERAPEUTICS, INC. 2015 NEW EMPLOYEE INCENTIVE PLAN CYTORI THERAPEUTICS, INC. 2015 New Employee Incentive Plan (Filed With SEC on January 5, 2016)
- Letter Agreement dated September 19, 2014, by and among the Company, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on November 7, 2014)
- CONFIDENTIAL (Filed With SEC on May 30, 2014)
- CYTORI THERAPEUTICS, INC. $40,000,000 SALESAGREEMENT (Filed With SEC on May 12, 2014)
- Puregraft Sale-License-Supply Agreement, dated July 30, 2013, by and among the Company and Bimini Technologies LLC (Filed With SEC on November 12, 2013)
- 26-107 (Filed With SEC on October 3, 2012)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 8, 2009)
- 4,771,174Shares Warrantsto Purchase6,679,644 Shares CYTORITHERAPEUTICS, INC. CommonStock PLACEMENT AGENCYAGREEMENT (Filed With SEC on March 10, 2009)
- SUBSCRIPTIONAGREEMENT (Filed With SEC on March 10, 2009)
- PROMISSORYNOTE (Filed With SEC on March 6, 2009)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on August 8, 2008)
- AMENDMENTNO. 1 TO MASTERCELL BANKING AND CRYOPRESERVATION AGREEMENT (Filed With SEC on June 10, 2008)
- AMENDMENTONE TO LICENCE/COMMERCIAL AGREEMENT (Filed With SEC on March 14, 2008)
- MASTER CELL BANKING AND CRYOPRESERVATION AGREEMENT (Filed With SEC on November 13, 2007)
- CYTORI THERAPEUTICS, INC. AMENDMENT NO. 2 TO RIGHTS AGREEMENT (Filed With SEC on September 4, 2007)
- SUBSCRIPTIONAGREEMENT (Filed With SEC on February 26, 2007)
- CONFIDENTIAL (Filed With SEC on February 26, 2007)
- PART-TIMEEMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2006)
- Agreement for Exclusive Right of Negotiation (Filed With SEC on May 15, 2006)
- SHAREHOLDERSAGREEMENT (Filed With SEC on March 30, 2006)
- LICENSE/COMMERCIAL AGREEMENT (Filed With SEC on March 30, 2006)
- MACROPOREBIOSURGERY, INC. AMENDMENTNO. 1 TO RIGHTS AGREEMENT (Filed With SEC on May 18, 2005)
- Salary and Bonuses for Named ExecutiveOfficers (Filed With SEC on May 12, 2005)
- between MACROPORE BIOSURGERY, INC a Delaware Corporation (MacroPore) and SENKO MEDICAL TRADING CO. a JapaneseCorporation (Senko) (Filed With SEC on November 15, 2004)
- General terms (Filed With SEC on November 15, 2004)
- OFFERLETTER FOR THE POSITION OF CHIEF FINANCIAL OFFICER (Filed With SEC on August 16, 2004)
- CONFIDENTIAL TREATMENT REQUESTED ASSETPURCHASE AGREEMENT*** (Filed With SEC on March 30, 2004)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on November 12, 2003)
- AMENDMENT (Filed With SEC on November 12, 2003)